2006
DOI: 10.1136/emj.2006.034637
|View full text |Cite
|
Sign up to set email alerts
|

Intranasal diamorphine integrated care pathway for paediatric analgesia in the accident and emergency department

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…The intranasal (IN) route has been investigated as an alternative [ 9 , 10 ], Lazanda® fentanyl nasal spray was approved by the FDA in July 2011 for the management of breakthrough pain in adult patients with cancer [ 11 ]. IN fentanyl administration might be preferred because IN delivery does not require establishment of IV access; thus, there are no inherent delays with drug-delivery preparation and administration, which would reduce time to analgesic relief compared with IV opioids [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…The intranasal (IN) route has been investigated as an alternative [ 9 , 10 ], Lazanda® fentanyl nasal spray was approved by the FDA in July 2011 for the management of breakthrough pain in adult patients with cancer [ 11 ]. IN fentanyl administration might be preferred because IN delivery does not require establishment of IV access; thus, there are no inherent delays with drug-delivery preparation and administration, which would reduce time to analgesic relief compared with IV opioids [ 12 ].…”
Section: Introductionmentioning
confidence: 99%